Wted Avg Med Wted Avg Med Medical Services Education Wted Avg Hrly Reimburse Reimburse (NP @ Reimbursement Reimbursement7 Reimburse 8 (Physician) (85%) Med nutr - New Patient, 99204 $149 $126 initial - 15 $124 Level 4 visit min Med nutri - Est. Patient, 99214 $97 $82 subsequent $108 Level 4 visit - 15 min Med - Facility Reimbursement group - 15 $55 min Self-manage New Patient, Ed, $121 $102 G0108 $46 4 visit individual, 30 min Established Self-manage $24 99214 Patient, 4 $74 $63 G0109 Ed, group, visit per 30 min Financial Outcomes The financial analysis was based on equivalent staffing models to ensure a fair comparison for the build vs. buy financial decision. Financial projections for both the Build and Joslin-buy Models were based on a ramp up of production in year one, with the Endocrinologist and the Nurse Practitioner functioning at 70% of capacity. 100% capacity would be realized in year two. A second Endocrinologist, functioning at 70% capacity, is projected to be added in year three to meet increasing patient demand due to marketing and a building reputation. Full production capacity for the second Endocrinologist is anticipated to be achieved in year four. Operating Revenue and Expenses For both the Build and Joslin-buy Models, revenue is generated from clinical and educational services provided at the Diabetes Center of Excellence. Neither model achieves positive net operating income within five years. The yearly franchise fee, which is adjusted to the CPI each year, accounts for the
Medical Services Reimbursement Wted Avg Med Reimburse (Physician) Wted Avg Med Reimburse (NP @ (85%) Education Reimbursement7 Wted Avg Hrly Reimburse 8 99204 New Patient, Level 4 visit $149 $126 Med nutr - initial - 15 min $124 99214 Est. Patient, Level 4 visit $97 $82 Med nutri - subsequent - 15 min $108 Facility Reimbursement Med - group - 15 min $55 New Patient, 4 visit $121 $102 G0108 Self-manage Ed, individual, 30 min $46 99214 Established Patient, 4 visit $74 $63 G0109 Self-manage Ed, group, per 30 min $24 Financial Outcomes The financial analysis was based on equivalent staffing models to ensure a fair comparison for the build vs. buy financial decision. Financial projections for both the Build and Joslin-buy Models were based on a ramp up of production in year one, with the Endocrinologist and the Nurse Practitioner functioning at 70% of capacity. 100% capacity would be realized in year two. A second Endocrinologist, functioning at 70% capacity, is projected to be added in year three to meet increasing patient demand due to marketing and a building reputation. Full production capacity for the second Endocrinologist is anticipated to be achieved in year four. Operating Revenue and Expenses For both the Build and Joslin-buy Models, revenue is generated from clinical and educational services provided at the Diabetes Center of Excellence. Neither model achieves positive net operating income within five years. The yearly franchise fee, which is adjusted to the CPI each year, accounts for the